GeoVax Labs, Inc. — Investor Relations & Filings
GeoVax Labs, Inc. is a clinical-stage biotechnology company that develops human vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms. The company's lead oncology program is Gedeptin®, a therapy for advanced head and neck cancers which has completed enrollment in a Phase 1/2 clinical trial. Its primary infectious disease candidate is GEO-CM04S1, a next-generation COVID-19 vaccine being evaluated in Phase 2 clinical trials for high-risk, immunocompromised populations and as a heterologous booster. GeoVax's development pipeline also includes research programs for preventive vaccines against Mpox, smallpox, hemorrhagic fever viruses such as Ebola and Marburg, malaria, and Zika virus, alongside therapies for various solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| GeoVax CEO Welcomes FIFA World Cup 2026 While Addressing Biothreat Readiness | 2026-06-01 | English | |
| Registration Now Open for Tribe Public CEO Presentation and Q&A Webinar Event | 2026-05-27 | English | |
| GeoVax Accelerates Focus on GEO-MVA Commercialization and Advancement of Oncology Program Gedeptin(R) | 2026-05-26 | English | |
| FORM S-1 | 2026-05-26 | English | |
| GeoVax Comments on Escalating Bundibugyo Ebola Outbreak and Growing Need for Flexible Biodefense Vaccine Platforms | 2026-05-20 | English | |
| FORM 8-K | 2026-05-19 | English |
Browse filings by year
21 years- 2026 64 filings
- 2025 94 filings
- 2024 98 filings
- 2023 48 filings
- 2022 55 filings
- 2021 47 filings
- 2020 54 filings
- 2019 36 filings
- 2018 32 filings
- 2017 37 filings
- 2016 60 filings
- 2015 57 filings
- 2014 37 filings
- 2013 42 filings
- 2012 43 filings
- 2011 20 filings
- 2010 90 filings
- 2009 48 filings
- 2008 43 filings
- 2007 37 filings
- 2006 31 filings
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
GeoVax Labs, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35063/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35063 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35063 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35063 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35063}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GeoVax Labs, Inc. (id: 35063)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.